We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
401
Target
TGT
$66.3B
– –
-4,577
Closed -$713K
TGTX icon
402
TG Therapeutics
TGTX
$8.19B
– –
-11,478
Closed -$268K
TKO icon
403
TKO Group
TKO
$14B
– –
-3,472
Closed -$430K
TLRY icon
404
Tilray
TLRY
$493M
– –
-17,694
Closed -$311K
TNC icon
405
Tennant Co
TNC
$1.44B
– –
-3,564
Closed -$342K
TNET icon
406
TriNet
TNET
$3.23B
– –
-4,744
Closed -$460K
TNGX icon
407
Tango Therapeutics
TNGX
$4.21B
– –
-1,540,000
Closed -$11.9M
TRDA icon
408
Entrada Therapeutics
TRDA
$254M
– –
-57,331
Closed -$916K
TRGP icon
409
Targa Resources
TRGP
$56.8B
– –
-1,776
Closed -$263K
TRMB icon
410
Trimble
TRMB
$13.6B
– –
-10,689
Closed -$664K
TRUP icon
411
Trupanion
TRUP
$1.13B
– –
-8,085
Closed -$339K
TSLA icon
412
Tesla
TSLA
$1.18T
– –
-2,789
Closed -$730K
TT icon
413
Trane Technologies
TT
$98.8B
– –
-2,799
Closed -$1.09M
TTWO icon
414
Take-Two Interactive
TTWO
$46.1B
– –
-3,785
Closed -$582K
TWO
415
Two Harbors Investment
TWO
$1.27B
– –
-56,550
Closed -$785K
UAA icon
416
Under Armour
UAA
$3.01B
– –
-184,457
Closed -$1.64M
UBER icon
417
Uber
UBER
$145B
– –
-10,476
Closed -$787K
UHS icon
418
Universal Health Services
UHS
$10.2B
– –
-1,730
Closed -$396K
UPBD icon
419
Upbound Group
UPBD
$1.22B
– –
-31,004
Closed -$992K
USAC icon
420
USA Compression Partners
USAC
$3.69B
– –
-30,692
Closed -$703K
USFD icon
421
US Foods
USFD
$22.5B
– –
-6,845
Closed -$421K
USNA icon
422
Usana Health Sciences
USNA
$419M
– –
-34,136
Closed -$1.29M
USPH icon
423
US Physical Therapy
USPH
$1.22B
– –
-10,214
Closed -$864K
UTL icon
424
Unitil
UTL
$989M
– –
-3,712
Closed -$225K
UTI icon
425
Universal Technical Institute
UTI
$2.26B
– –
-35,726
Closed -$581K
15 16
17
18 19

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.